
Bohdi’s treatment for rare epilepsy begins, seizures stop three days after first dose
The story in brief
Dr Kavitha Kothava led a breakthrough in treating Bohdi Higginson, a NSW baby with KCNT1-related catastrophic epilepsy, an ultra-rare disorder with no known effective treatment. The treatment, developed overseas, was administered through Sydney’s Innovative Therapies Pathway. Bohdi’s first dose was on April 21, and he had his final seizure three days later. The treatment, which showed promise in animal studies, remains under monitoring for long-term effects.